Pfizer's (PFE) COVID Pill Best in Class, Will Put Pressure on Merck (MRK) and Regeneron (REGN) - Analyst
Tweet Send to a Friend
(Updated - November 5, 2021 8:54 AM EDT)Earlier today, Pfizer Inc. (NYSE: PFE) announced its investigational novel COVID-19 oral antiviral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
